Cargando…
Turning antibodies off and on again using a covalently tethered blocking peptide
In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741643/ https://www.ncbi.nlm.nih.gov/pubmed/36496512 http://dx.doi.org/10.1038/s42003-022-04094-1 |
_version_ | 1784848370036113408 |
---|---|
author | Brasino, Michael Wagnell, Eli Hamilton, Sean Ranganathan, Srivathsan Gomes, Michelle M. Branchaud, Bruce Messmer, Bradley Ibsen, Stuart D. |
author_facet | Brasino, Michael Wagnell, Eli Hamilton, Sean Ranganathan, Srivathsan Gomes, Michelle M. Branchaud, Bruce Messmer, Bradley Ibsen, Stuart D. |
author_sort | Brasino, Michael |
collection | PubMed |
description | In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “on-state” with temporal and spatial control can address this. Here we demonstrate a method to modulate binding activity of antibodies in a predictable and reproducible way. We designed a blocking construct that uses both covalent and non-covalent interactions with the antibody. The construct consisted of a Protein L protein attached to a flexible linker ending in a blocking-peptide designed to interact with the antibody binding site. A mutant Protein L was developed to enable photo-triggered covalent crosslinking to the antibody at a specific location. The covalent bond anchored the linker and blocking peptide to the antibody light chain keeping the blocking peptide close to the antibody binding site. This effectively put the antibody into an “off-state”. We demonstrate that protease-cleavable and photocleavable moieties in the tether enable controlled antibody activation to the “on-state” for anti-FLAG and cetuximab antibodies. Protein L can bind a range of antibodies used therapeutically and in research for wide applicability. |
format | Online Article Text |
id | pubmed-9741643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97416432022-12-12 Turning antibodies off and on again using a covalently tethered blocking peptide Brasino, Michael Wagnell, Eli Hamilton, Sean Ranganathan, Srivathsan Gomes, Michelle M. Branchaud, Bruce Messmer, Bradley Ibsen, Stuart D. Commun Biol Article In their natural form, antibodies are always in an “on-state” and are capable of binding to their targets. This leads to undesirable interactions in a wide range of therapeutic, analytical, and synthetic applications. Modulating binding kinetics of antibodies to turn them from an “off-state” to an “on-state” with temporal and spatial control can address this. Here we demonstrate a method to modulate binding activity of antibodies in a predictable and reproducible way. We designed a blocking construct that uses both covalent and non-covalent interactions with the antibody. The construct consisted of a Protein L protein attached to a flexible linker ending in a blocking-peptide designed to interact with the antibody binding site. A mutant Protein L was developed to enable photo-triggered covalent crosslinking to the antibody at a specific location. The covalent bond anchored the linker and blocking peptide to the antibody light chain keeping the blocking peptide close to the antibody binding site. This effectively put the antibody into an “off-state”. We demonstrate that protease-cleavable and photocleavable moieties in the tether enable controlled antibody activation to the “on-state” for anti-FLAG and cetuximab antibodies. Protein L can bind a range of antibodies used therapeutically and in research for wide applicability. Nature Publishing Group UK 2022-12-10 /pmc/articles/PMC9741643/ /pubmed/36496512 http://dx.doi.org/10.1038/s42003-022-04094-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Brasino, Michael Wagnell, Eli Hamilton, Sean Ranganathan, Srivathsan Gomes, Michelle M. Branchaud, Bruce Messmer, Bradley Ibsen, Stuart D. Turning antibodies off and on again using a covalently tethered blocking peptide |
title | Turning antibodies off and on again using a covalently tethered blocking peptide |
title_full | Turning antibodies off and on again using a covalently tethered blocking peptide |
title_fullStr | Turning antibodies off and on again using a covalently tethered blocking peptide |
title_full_unstemmed | Turning antibodies off and on again using a covalently tethered blocking peptide |
title_short | Turning antibodies off and on again using a covalently tethered blocking peptide |
title_sort | turning antibodies off and on again using a covalently tethered blocking peptide |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741643/ https://www.ncbi.nlm.nih.gov/pubmed/36496512 http://dx.doi.org/10.1038/s42003-022-04094-1 |
work_keys_str_mv | AT brasinomichael turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT wagnelleli turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT hamiltonsean turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT ranganathansrivathsan turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT gomesmichellem turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT branchaudbruce turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT messmerbradley turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide AT ibsenstuartd turningantibodiesoffandonagainusingacovalentlytetheredblockingpeptide |